Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_assertion type Assertion NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_head.
- NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_assertion description "[Due to its restricted expression pattern and immunogenicity FAM46D represents a novel target for cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_provenance.
- NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_assertion evidence source_evidence_literature NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_provenance.
- NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_assertion SIO_000772 19540335 NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_provenance.
- NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_assertion wasDerivedFrom befree-20140225 NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_provenance.
- NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_assertion wasGeneratedBy ECO_0000203 NP496602.RAW84jO-zxhEWsW9L5MJcPuegE-qpckH0X_6WYpdlg3ZE130_provenance.